Insights On Pharmaceutical Logistics
-
Pharmaceutical Supply Chain Management Best Practices
9/13/2024
Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.
-
Integrated Single-Site CDMO Model
3/16/2026
A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.
-
Shedding Light On Photo-Stability Forced Degradation
11/26/2024
Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.
-
Risk Mitigation For Late-Stage Clinical Assets
6/11/2025
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.
-
Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies
7/11/2024
The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.
-
Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters
11/11/2025
Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.
-
Performance Of Mobius® Bag Assemblies With Ultimus® Film In Truck Shipping Simulation Test
10/29/2024
Explore findings from a study testing Mobius® single-use bags under rigorous shipping conditions, demonstrating the suitability for transporting various liquid volumes while preserving their integrity.
-
How To Select The Right Fill-Finish CDMO For Phase I–II
3/16/2026
Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.
-
Selecting An Off-Site GMP Storage Provider
5/8/2024
Understanding how to select a reliable off-site storage provider will empower you to ensure the integrity and accessibility of your valuable biopharmaceutical products, materials, and samples.
-
Fast-Track Innovation, Address CMC Challenges In Expedited Pathways
1/26/2026
Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.